NURS 329 ACTUAL TEST PAPER 2026
QUESTIONS WITH SOLUTIONS GRADED A+
◉ A patient has been prescribed pharmacologic doses of glucocorticoids.
It is most important for the nurse to teach the patient to do what?
A. Increase intake of dietary sodium.
B. Take antibiotics to prevent infection.
C. Never abruptly withdraw therapy.
D. Have an eye examination every year. Answer: C. Never abruptly
withdraw therapy.
◉ Which of the following drugs has no anti-inflammatory properties and
blocks transmission of pain impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above. Answer: A. Acetaminophen (Tylenol)
◉ The nurse is caring for a patient with anemia related to chronic renal
failure. Which agent might be used to treat the anemia?
,a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]. Answer: d. Epoetin alfa [Procrit]
◉ The nurse is administering epoetin alfa [Procrit] to a patient receiving
chemotherapy. Which adverse effect is a potential risk with this drug?
a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain. Answer: a. Accelerated tumor progression
◉ The nurse is caring for a patient undergoing cancer chemotherapy
who presents with rash, bone pain, hypertension, and pedal edema.
Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet. Answer: b. Bone pain
,◉ The nurse is evaluating the effectiveness of the drug oprelvekin
[Neumega] in a patient undergoing cancer chemotherapy. Which finding
is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
d. Total lymphocyte count of 1000/mm3. Answer: a. Platelet count of
150 × 103/mm3
◉ Which finding indicates a positive outcome from treatment with
filgrastim [Neupogen]?
a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.. Answer: b. The neutrophil count
increases.
◉ The healthcare provider prescribes hematopoietic growth factor for a
patient. The nurse should notify the healthcare provider to question the
prescription for which patient condition?
, a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus (HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced
anemia. Answer: b. A patient with uncontrolled hypertension
◉ A patient with nonmyeloid cancer is receiving oprelvekin [Neumega].
Which adverse effects are most likely associated with this drug? (Select
all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions. Answer: c, d, and e
◉ The nurse should review which baseline data before starting epoetin
alfa [Epogen] therapy in a patient with chronic renal failure (CRF)?
(Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
QUESTIONS WITH SOLUTIONS GRADED A+
◉ A patient has been prescribed pharmacologic doses of glucocorticoids.
It is most important for the nurse to teach the patient to do what?
A. Increase intake of dietary sodium.
B. Take antibiotics to prevent infection.
C. Never abruptly withdraw therapy.
D. Have an eye examination every year. Answer: C. Never abruptly
withdraw therapy.
◉ Which of the following drugs has no anti-inflammatory properties and
blocks transmission of pain impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above. Answer: A. Acetaminophen (Tylenol)
◉ The nurse is caring for a patient with anemia related to chronic renal
failure. Which agent might be used to treat the anemia?
,a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]. Answer: d. Epoetin alfa [Procrit]
◉ The nurse is administering epoetin alfa [Procrit] to a patient receiving
chemotherapy. Which adverse effect is a potential risk with this drug?
a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain. Answer: a. Accelerated tumor progression
◉ The nurse is caring for a patient undergoing cancer chemotherapy
who presents with rash, bone pain, hypertension, and pedal edema.
Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet. Answer: b. Bone pain
,◉ The nurse is evaluating the effectiveness of the drug oprelvekin
[Neumega] in a patient undergoing cancer chemotherapy. Which finding
is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
d. Total lymphocyte count of 1000/mm3. Answer: a. Platelet count of
150 × 103/mm3
◉ Which finding indicates a positive outcome from treatment with
filgrastim [Neupogen]?
a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.. Answer: b. The neutrophil count
increases.
◉ The healthcare provider prescribes hematopoietic growth factor for a
patient. The nurse should notify the healthcare provider to question the
prescription for which patient condition?
, a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus (HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced
anemia. Answer: b. A patient with uncontrolled hypertension
◉ A patient with nonmyeloid cancer is receiving oprelvekin [Neumega].
Which adverse effects are most likely associated with this drug? (Select
all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions. Answer: c, d, and e
◉ The nurse should review which baseline data before starting epoetin
alfa [Epogen] therapy in a patient with chronic renal failure (CRF)?
(Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
